Discussion about this post

User's avatar
Allan MacRae's avatar

6170 Albertans were killed in WW1 and 2943 killed in WW2 for a total of 9113.

I calculated Alberta total Covid-19 "vaccine+lockdown"-caused deaths from 1H2021 to 1H2023 at 10,500.

So Jason and Rachel have now killed more Albertans than we lost in WW1 and WW2...

... and it looks like Danielle has bought into the scamdemic. We had better hopes for her.

Expand full comment
Allan MacRae's avatar

From my Chapter above:

“That does not include another 500,000 avoidable American deaths in 2020, needlessly killed by late treatment, remdesivir and ventilators.”

In plain language, Remdesivir is a killer drug that blows out liver and kidneys. Part of the Great Cull.

Regards, Allan

REMDESIVIR AND ACUTE RENAL FAILURE: A POTENTIAL SAFETY SIGNAL FROM DISPROPORTIONALITY ANALYSIS OF THE WHO SAFETY DATABASE

https://pubmed.ncbi.nlm.nih.gov/33340409/

Thanks to Dr Paul Alexander

[excerpt]

‘Remdesivir is approved for emergency use by the US Food and Drug Administration (FDA) and authorized conditionally by the European Medicines Agency (EMA) for patients with coronavirus disease 2019 (COVID-19). Its benefit-risk ratio is still being explored because data in the field are rather scant.

A decrease of the creatinine clearance associated with remdesivir has been inconstantly reported in clinical trials with unclear relevance. Despite these uncertainties, we searched for a potential signal of acute renal failure (ARF) in pharmacovigilance postmarketing data.

An analysis of the international pharmacovigilance postmarketing databases (VigiBase) of the World Health Organization (WHO) was performed, using two disproportionality methods. Reporting odds ratio (ROR) compared the number of ARF cases reported with remdesivir, with those reported with other drugs prescribed in comparable situations of COVID-19 (hydroxychloroquine, tocilizumab, and lopinavir/ritonavir).

The combination of the terms "acute renal failure" and "remdesivir" yielded a statistically significant disproportionality signal with 138 observed cases instead of the 9 expected. ROR of ARF with remdesivir was 20-fold (20.3; confidence interval 0.95 [15.7-26.3], P < 0.0001]) that of comparative drugs.

Based on ARF cases reported in VigiBase, and despite the caveats inherent to COVID-19 circumstances, we detected a statistically significant pharmacovigilance signal of nephrotoxicity associated with remdesivir, deserving a thorough qualitative assessment of all available data. Meanwhile, as recommended in its Summary of Product Characteristics, assessment of patients with COVID-19 renal function should prevail before and during treatment with remdesivir in COVID-19.’

Expand full comment
5 more comments...

No posts